Correlation Between Epistaxis and Cardiovascular Disease
NCT ID: NCT02677467
Last Updated: 2016-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2016-03-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atmospheric Pressure and Epistaxis Relationship
NCT06531577
Isometric Handgrip Training Frequency and Blood Pressure in People With Hypertension
NCT06335433
Cardiovascular Responses to Cold in Hypertension
NCT02007031
Smartphone App Assisted Home Blood Pressure Monitoring Amongst Hypertensive Patients in Singapore
NCT03209024
The Dose Response Effect of Isometric Handgrip Training Frequency on Blood Pressure in Normotensive Individuals
NCT06329804
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A participant is visit in the ER who patient with epistaxis.
Investigators will enroll 50 patients with epistaxis. Exclusion criteria is that patient needs immediately treatment for hypertensive urgency or patient with nasal trauma.
Investigators examine blood-pressure (BP) at five times in Emergency Department (ED) and out-patient department (opd) of Otorhinolaryngology (OL) . Investigators explain this study and ask to write consent for participant. After proper management of epistaxis, investigators get blood sampling of the participant and, the participant has a reservation to "opd of cardiovascular division of Internal Medicine" (CV opd) in the hospital.
When the participant visit CV opd, the participant undergo 24-hours-BP-monitoring and Pulse wave velocity (PWV).
After that, the participant will be follow-up for 3 months.
Investigators collect 50 data from 50 participants as a registry and analyze the data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Spontaneous epistaxis
A participant enroll if their age is over 18 with spontaneous epistaxis and their cause of visiting ER is spontaneous epistaxis. Exclusion criteria is that they needs immediately treatment for hypertensive urgency. And, they don't want to participate in this investigation. Investigators examine their blood-pressure variability and cardiovascular risk throughout their blood sample analysis.
Blood-pressure variability
Day to Night Blood pressure variability
Bleeding of wound
A participant enroll if their age is over 18 with bleeding of wound and their cause of visiting ER is to bleed on wound. Exclusion criteria is that their wounds' condition is serious or their pain is much severe. And, they don't want to participate in this investigation. Investigators examine their blood-pressure variability and cardiovascular risk throughout their blood sample analysis.
Blood-pressure variability
Day to Night Blood pressure variability
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood-pressure variability
Day to Night Blood pressure variability
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age is over 18 with bleeding of wound
Exclusion Criteria
* they don't want to participate in this investigation.
Group B
* their wounds' condition is serious or their pain is much severe.
* they don't want to participate in this investigation.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hanyang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LEE YOON-JE
Fellowship, Emergency Medincine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
JUNGHOON SHIN, M.D., Ph.D.
Role: STUDY_CHAIR
Hanyang University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanyang University Guri Hospital
Guri-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Gurivengers
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.